KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Exact Sciences (EXAS) Receivables - Net (2016 - 2025)

Exact Sciences (EXAS) has disclosed Receivables - Net for 12 consecutive years, with $298.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 19.96% to $298.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $298.7 million, a 19.96% increase, with the full-year FY2025 number at $298.7 million, up 19.96% from a year prior.
  • Receivables - Net was $298.7 million for Q4 2025 at Exact Sciences, down from $306.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $353.3 million in Q2 2025 to a low of $158.0 million in Q4 2022.
  • A 5-year average of $235.5 million and a median of $233.6 million in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: skyrocketed 82.89% in 2021, then decreased 27.05% in 2022.
  • Exact Sciences' Receivables - Net stood at $216.6 million in 2021, then decreased by 27.05% to $158.0 million in 2022, then rose by 28.84% to $203.6 million in 2023, then increased by 22.27% to $249.0 million in 2024, then grew by 19.96% to $298.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Receivables - Net are $298.7 million (Q4 2025), $306.1 million (Q3 2025), and $353.3 million (Q2 2025).